tiprankstipranks
Acrivon Therapeutics, Inc. (ACRV)
NASDAQ:ACRV
US Market

Acrivon Therapeutics, Inc. (ACRV) Stock News & Sentiment

108 Followers
Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
PremiumPress Releases
Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
2d ago
Acrivon Therapeutics Reports Breakthrough Results and Solid Finances
PremiumCompany Announcements
Acrivon Therapeutics Reports Breakthrough Results and Solid Finances
22d ago
Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event
PremiumPress Releases
Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event
22d ago
Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316
PremiumPress Releases
Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316
30d ago
Acrivon Therapeutics Presents Data at AACR Annual Meeting Highlighting the Capabilities of Acrivon Predictive Precision Proteomics (AP3) for the Discovery of ACR-2316, a Novel, Selective WEE1/PKMYT1 Inhibitor, and the Identification of Actionable Resistance Mechanisms to ACR-368
PremiumPress Releases
Acrivon Therapeutics Presents Data at AACR Annual Meeting Highlighting the Capabilities of Acrivon Predictive Precision Proteomics (AP3) for the Discovery of ACR-2316, a Novel, Selective WEE1/PKMYT1 Inhibitor, and the Identification of Actionable Resistance Mechanisms to ACR-368
1M ago
Acrivon Therapeutics Secures $130M for Drug Development Expansion
PremiumCompany Announcements
Acrivon Therapeutics Secures $130M for Drug Development Expansion
1M ago
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
PremiumPress Releases
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
2M ago
More ACRV News >

News Score - Last 7 Days

Neutral
ACRV
Sector Average
Media Buzz
This Week5 articles
Weekly Average3 articles
News Sentiment
This Week100%
Sector Average62%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ACRV’s Media Buzz Sentiment?
5 articles about ACRV were published this week. In an average week, 3 articles are published.
    What is ACRV’s weekly average amount of articles?
    In an average week, 3 articles about ACRV are published.
      What is ACRV’s News Sentiment?
      100% of articles about ACRV were positive this week, compared to its sector average of 62%.
        Healthcare Stocks that are Trending in the News
        MTDMettler-Toledo
        ALCAlcon
        CABACabaletta Bio
        PYXSPyxis Oncology
        BOLTBolt Biotherapeutics
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis